Literature DB >> 22309832

Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

Huiping Tan1, Zihui Xu, Peng Jin.   

Abstract

Increasingly complex networks of noncoding RNAs are being found to play important and diverse roles in the regulation of gene expression throughout the genome. Many lines of evidence are linking mutations and dysregulations of noncoding RNAs to a host of human diseases, and noncoding RNAs have been implicated in the molecular pathogenesis of some neurodegenerative disorders. The expansion of trinucleotide repeats is now recognized as a major cause of neurological disorders. Here we will review our current knowledge of the proposed mechanisms behind the involvement of noncoding RNAs in the molecular pathogenesis of neurodegenerative disorders, particularly the sequestration of specific RNA-binding proteins, the regulation of antisense transcripts, and the role of the microRNA pathway in the context of known neurodegenerative disorders caused by the expansion of trinucleotide repeats.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309832      PMCID: PMC3345102          DOI: 10.1016/j.expneurol.2012.01.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  84 in total

1.  Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.

Authors:  H Seznec; O Agbulut; N Sergeant; C Savouret; A Ghestem; N Tabti; J C Willer; L Ourth; C Duros; E Brisson; C Fouquet; G Butler-Browne; A Delacourte; C Junien; G Gourdon
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

2.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

3.  The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Authors:  Rob Willemsen; Marianne Hoogeveen-Westerveld; Surya Reis; Joan Holstege; Lies-Anne W F M Severijnen; Ingeborg M Nieuwenhuizen; Mariette Schrier; Leontine van Unen; Flora Tassone; Andre T Hoogeveen; Paul J Hagerman; Edwin J Mientjes; Ben A Oostra
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

4.  Spinocerebellar ataxia type 8: clinical features in a large family.

Authors:  J W Day; L J Schut; M L Moseley; A C Durand; L P Ranum
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

5.  RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1.

Authors:  N A Timchenko; Z J Cai; A L Welm; S Reddy; T Ashizawa; L T Timchenko
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

6.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

Authors:  C M Greco; R J Hagerman; F Tassone; A E Chudley; M R Del Bigio; S Jacquemont; M Leehey; P J Hagerman
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

7.  RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila.

Authors:  Peng Jin; Daniela C Zarnescu; Fuping Zhang; Christopher E Pearson; John C Lucchesi; Kevin Moses; Stephen T Warren
Journal:  Neuron       Date:  2003-08-28       Impact factor: 17.173

8.  Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.

Authors:  Ami Mankodi; Masanori P Takahashi; Hong Jiang; Carol L Beck; William J Bowers; Richard T Moxley; Stephen C Cannon; Charles A Thornton
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

9.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.

Authors:  Nicolas Charlet-B; Rajesh S Savkur; Gopal Singh; Anne V Philips; Elizabeth A Grice; Thomas A Cooper
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

10.  Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.

Authors:  Chiara Zuccato; Marzia Tartari; Andrea Crotti; Donato Goffredo; Marta Valenza; Luciano Conti; Tiziana Cataudella; Blair R Leavitt; Michael R Hayden; Tõnis Timmusk; Dorotea Rigamonti; Elena Cattaneo
Journal:  Nat Genet       Date:  2003-07-27       Impact factor: 38.330

View more
  9 in total

Review 1.  The unstable repeats--three evolving faces of neurological disease.

Authors:  David L Nelson; Harry T Orr; Stephen T Warren
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

Review 2.  Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Authors:  Seren Marsh; Britt Hanson; Matthew J A Wood; Miguel A Varela; Thomas C Roberts
Journal:  Mol Ther       Date:  2020-10-14       Impact factor: 11.454

Review 3.  A brief history of triplet repeat diseases.

Authors:  Helen Budworth; Cynthia T McMurray
Journal:  Methods Mol Biol       Date:  2013

4.  Cross-species Exon Capture and Whole Exome Sequencing: Application, Utility and Challenges for Genomic Resource Development in Non-model Species.

Authors:  T Jackson; E Ishengoma; C Rhode
Journal:  Mar Biotechnol (NY)       Date:  2021-07-09       Impact factor: 3.619

5.  From Transcriptome to Noncoding RNAs: Implications in ALS Mechanism.

Authors:  Stella Gagliardi; Pamela Milani; Valentina Sardone; Orietta Pansarasa; Cristina Cereda
Journal:  Neurol Res Int       Date:  2012-06-17

Review 6.  Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review.

Authors:  João M Da Conceição Alves-Cruzeiro; Liliana Mendonça; Luís Pereira de Almeida; Clévio Nóbrega
Journal:  Front Neurosci       Date:  2016-12-15       Impact factor: 4.677

Review 7.  Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy.

Authors:  Miguel A Varela; Thomas C Roberts; Matthew J A Wood
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

8.  Approaches to manipulating microRNAs in neurogenesis.

Authors:  Haijun Zhang; Benjamin Shykind; Tao Sun
Journal:  Front Neurosci       Date:  2013-01-17       Impact factor: 4.677

9.  A 1 bp deletion in HACE1 causes ataxia in Norwegian elkhound, black.

Authors:  Kim K L Bellamy; Fredrik S Skedsmo; Josefin Hultman; Ellen F Arnet; Ole Albert Guttersrud; Hege Kippenes Skogmo; Stein Istre Thoresen; Arild Espenes; Karin Hultin Jäderlund; Frode Lingaas
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.